David F. Welch

David F. Welch (board member) discloses dealings in 3 companies, chiefly Infinera Corp, Rezolute, Inc. and CytoDyn Inc. In total, 156 filings cover trades dated from 5 February 2016 to 28 February 2025.

On the open market, the record shows 16 purchases worth €80k and 31 sales worth €11.2M. Netting one side against the other leaves €11.1M of net selling. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. The rest of the record consists of 31 share grants and 78 option exercises.

In size, the median ticket on the buying side is €4,497. Across 16 purchases, this insider has always bought alone, with no colleague buying within 30 days.

On 3 March 2025 came the latest disclosure, an option exercise in Infinera Corp. The last insider purchase was made public on 15 March 2017, 3,506 days ago. The median gap between a trade and its publication by SEC (Form 4) is 3 days. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.